A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone.

Saved in:
Bibliographic Details
Title: A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone.
Authors: Schepers AJ; 1 Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA., Jones AR; 1 Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA., Reeves BN; 2 Division of Hematology and Oncology, Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Tuchman SA; 2 Division of Hematology and Oncology, Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Bates JS; 1 Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2019 Oct; Vol. 25 (7), pp. 1692-1698. Date of Electronic Publication: 2018 Nov 30.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-092X
DOI:10.1177/1078155218815283